For: | Libânio D, Marinho RT. Impact of hepatitis C oral therapy in portal hypertension. World J Gastroenterol 2017; 23(26): 4669-4674 [PMID: 28765688 DOI: 10.3748/wjg.v23.i26.4669] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v23/i26/4669.htm |
Number | Citing Articles |
1 |
Tomoya Sano, Keisuke Amano, Tatsuya Ide, Keiji Yokoyama, Kazunori Noguchi, Hiroki Nakamura, Hiroshi Isoda, Miki Ohno, Miki Shirachi, Yasuyo Morita, Yoichi Yano, Shuji Sumie, Toshihiro Kawaguchi, Reiichiro Kuwahara, Teruko Arinaga‐Hino, Hirokazu Takahashi, Satoshi Shakado, Fumihito Hirai, Takumi Kawaguchi. A combination of hepatic encephalopathy and body mass index was associated with the point of no return for improving liver functional reserve after sofosbuvir/velpatasvir treatment in patients with hepatitis C virus‐related decompensated cirrhosis. Hepatology Research 2023; 53(1): 26 doi: 10.1111/hepr.13837
|
2 |
Rui Cao, Xiangyu Lu, Yilei Wu, Siyu Li, Jun Gong. Laparoscopic Splenectomy and Esophagogastric Devascularization Versus Endoscopic Varices Ligation Plus Laparoscopic Splenectomy in the Treatment of Portal Hypertension. Journal of Laparoendoscopic & Advanced Surgical Techniques 2023; 33(11): 1052 doi: 10.1089/lap.2023.0243
|
3 |
Christine E. Dolin, Toshifumi Sato, Michael L. Merchant, Gavin E. Arteel. Extracellular Matrix Omics. Biology of Extracellular Matrix 2020; 7: 43 doi: 10.1007/978-3-030-58330-9_3
|
4 |
Thomas Reiberger. The Value of Liver and Spleen Stiffness for Evaluation of Portal Hypertension in Compensated Cirrhosis. Hepatology Communications 2022; 6(5): 950 doi: 10.1002/hep4.1855
|
5 |
UEG Week 2019 Poster Presentations. United European Gastroenterology Journal 2019; 7(S8): 189 doi: 10.1177/2050640619854671
|
6 |
Yukihisa Yuri, Hiroki Nishikawa, Hirayuki Enomoto, Kazunori Yoh, Yoshinori Iwata, Yoshiyuki Sakai, Kyohei Kishino, Naoto Ikeda, Tomoyuki Takashima, Nobuhiro Aizawa, Ryo Takata, Kunihiro Hasegawa, Noriko Ishii, Takashi Nishimura, Hiroko Iijima, Shuhei Nishiguchi. Impact of Sustained Virological Response for Gastroesophageal Varices in Hepatitis-C-Virus-Related Liver Cirrhosis. Journal of Clinical Medicine 2019; 9(1): 95 doi: 10.3390/jcm9010095
|
7 |
Dmitry Victorovich Garbuzenko, Nikolay Olegovich Arefyev. Primary prevention of bleeding from esophageal varices in patients with liver cirrhosis: An update and review of the literature. Journal of Evidence-Based Medicine 2020; 13(4): 313 doi: 10.1111/jebm.12407
|
8 |
Jian-an Yu, Si-wei Yang, Yu Wang, Jian Li, Tian-hao Su, Jiang Chang, Guang Chen. The Balloon Catheter Method and the End-hole Catheter Method in the Measurement of Hepatic Venous Pressure Gradient: a Comparative Study. CardioVascular and Interventional Radiology 2024; 47(10): 1356 doi: 10.1007/s00270-024-03814-w
|
9 |
Myung Hee Kim, Duk Ki Kim, Hyuk Soo Eun, Woo Sun Rou, Seok Hyun Kim, Byung Seok Lee. Refractory Hepatic Hydrothorax in Chronic Hepatitis C Controlled by Direct-acting Antivirals. The Korean Journal of Gastroenterology 2020; 75(2): 98 doi: 10.4166/kjg.2020.75.2.98
|
10 |
Shailja ., Shruti Radera, Sumit Rungta, Amar Jeet, Amita Jain. Sustained Virological Response After Direct-Acting Antiviral Therapy in Hepatitis C Virus-Infected Individuals With and Without Decompensated Liver Cirrhosis: A One-Year Follow-Up Study. Cureus 2025; doi: 10.7759/cureus.79766
|
11 |
Ferron Ocampo, Carlo Sacdalan, Suteeraporn Pinyakorn, Misti Paudel, Tanyaporn Wansom, Nathornsorn Poltubtim, Somchai Sriplienchan, Nittaya Phanuphak, Robert Paul, Denise Hsu, Donn Colby, Lydie Trautmann, Serena Spudich, Phillip Chan. Neuropsychiatric and laboratory outcomes of hepatitis C treatment in an early-treated HIV cohort in Thailand. AIDS Research and Therapy 2025; 22(1) doi: 10.1186/s12981-025-00707-x
|
12 |
El‐Sayed Ibrahim, Mohamed Abdel‐Samiee, Mohamed I. Youssef, Helmy El‐Shazly, Abd‐ElAleem A.El‐Gendy, Ayman Ahmed Sakr, Doaa Elwazzan, Mervat Ragab Nassar, Amr Aly Elshormilisy, Ahmad Madkour, Mostafa Kamal, Yasmine M. Amrousy, Sally Waheed Elkhadry, Eman Abdelsameea. Variceal recurrence 4 years post endoscopic band ligation in hepatitis C patients who achieved sustained virological response with oral direct‐acting antiviral therapy. Journal of Viral Hepatitis 2021; 28(2): 279 doi: 10.1111/jvh.13426
|
13 |
Heba Ahmed Faheem, Nannes Adel Abdulmeged, Hany Aly Hussein, Ahmed Abdelaziz Elmoursi, Heba T-allah Mohammed Yousry Elnaggar, Ramy Samir Ghait. Impact of sustained virologic response in regression of portal hypertension in Egyptian patients with hepatitis C virus-associated cirrhosis and portal hypertension. Egyptian Liver Journal 2022; 12(1) doi: 10.1186/s43066-022-00188-x
|
14 |
Christophe Bureau, Hélène Larrue, Miriam Cortes-Cerisuleo, Roberto Miraglia, Bogdan Procopet, Marika Rudler, Jonel Trebicka, Lisa B. VanWagner, Virginia Hernandez-Gea. EASL Clinical Practice Guidelines on TIPS. Journal of Hepatology 2025; doi: 10.1016/j.jhep.2025.01.029
|
15 |
Anikó Folhoffer, Aladár D. Rónaszéki, Bettina K. Budai, Petra Borsos, Vince Orbán, Gabriella Győri, Ferenc Szalay, Pál N. Kaposi. Follow-Up of Liver Stiffness with Shear Wave Elastography in Chronic Hepatitis C Patients in Sustained Virological Response Augments Clinical Risk Assessment. Processes 2021; 9(5): 753 doi: 10.3390/pr9050753
|
16 |
Hiroshi Hisanaga, Hidetoshi Takedatsu, Keigo Emori, Hiroto Inoue, Yasuhumi Kunitake, Tomoyuki Nakane, Shuhei Fukunaga, Tatsuya Ide, Keiichi Mitsuyama, Takuji Torimura. Effect of Direct-Acting Antiviral Agents on Gastroesophageal Varices in Patients with Hepatitis C Virus-Related Cirrhosis. Medicina 2022; 58(8): 1077 doi: 10.3390/medicina58081077
|